AGP Executive Report
Last update: 2 hours agoCannabinoid Science: A new explainer breaks down CBN—why it’s showing up in “sleep” gummies and what the human research actually supports (mixed results, and many products bundle CBN with other actives). Medical Cannabis Product Push: Avicanna unveiled a QUIX™ rapid-onset medical cannabis portfolio, with initial SKUs planned for Canadian channels in Q3 2026. Regulated Market & Compliance: Los Angeles County launched a free Cannabis Social Equity Entrepreneurship Academy to prep residents for future retail/delivery licensing in unincorporated areas. Enforcement & Safety: Singapore charged a man after ICA found concealed vape pods at Woodlands Checkpoint under tougher 2026 vaporiser penalties. Industry Business: Ray’s Lemonade expanded its Vice line with THC-infused cream sodas, leaning on food-science formulation and measured dosing. Research & Risk: A teen-focused study links frequent cannabis use to changes in the dopamine reward system, with higher-potency products showing stronger effects. Global Drug Policy: A UN World Drug Report says drugs are “winning” the global war, with record cocaine production and shifting smuggling tactics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.